Oligosaccharides from bovine milk, whey and dairy products, and methods of producing bovine milk oligosaccharides are provided.

The present invention relates to a composition comprising collagen hydrolysate and amorphous gelatin, said composition being non-agglomerated. The invention is particularly useful in the production of various food products, more particularly healthy food products in need of texture. Also the invention is useful in the production of pet food, cosmetic or pharmaceutical products.

The nutraceutical composition includes a gelling component in a sufficient amount to provide a cohesive gelled product, and a peptide chelated mineral composition. In one embodiment, the peptide chelated mineral composition includes a collagen chelated mineral composition.

The nutraceutical composition includes a gelling component in a sufficient amount to provide a cohesive gelled product, and a peptide chelated mineral composition. In one embodiment, the peptide chelated mineral composition includes a collagen chelated mineral composition.

A surgical recovery supplement is disclosed herein. One surgical recovery supplement includes one or more probiotics, one or more forms of fiber, and one or more collagens. Some surgical recovery supplements further include one or more minerals, one or more vitamins, one or more enzymes, one or more antioxidants, and/or one or more extracts. Methods for using the surgical recovery supplements are also disclosed herein. One method includes taking a three times dose of a surgical supplement once a day for 30 days. Another method includes taking a single dose of a surgical supplement three times a day for 30 days.

A surgical recovery supplement is disclosed herein. One surgical recovery supplement includes one or more probiotics, one or more forms of fiber, and one or more collagens. Some surgical recovery supplements further include one or more minerals, one or more vitamins, one or more enzymes, one or more antioxidants, and/or one or more extracts. Methods for using the surgical recovery supplements are also disclosed herein. One method includes taking a three times dose of a surgical supplement once a day for 30 days. Another method includes taking a single dose of a surgical supplement three times a day for 30 days.

Process for the preparation of a fibrous product comprising protein and having a moisture content of at least 65% by weight by first preparing a homogenous mixture of protein material comprising cheese, a moisture binder material, a calcium-complex forming agent and water at a temperature between 70 and 90° C. under high shear with the pH of the homogenous mixture being from 6.4 to 7.5. The homogenous mixture has a water content of at least 75% by weight whilst total protein content is from 5 to 20% by weight. Into this homogenous mixture is mixed a hydrocolloid which precipitates with metal cations, after which a solution of a metal cation with a valency of at least 2 is added in order to form the fibrous product. This fibrous product is then isolated and cooled. The fibrous product thus obtained is particularly suitable for use in preparing meat substitute products.

The present disclosure provides methods and compositions useful for the production of slaughter-free meat products, and the characterizations of the same. The slaughter-free meat products contain several points of distinction when compared to conventional meat procured by harvesting the tissue of a dead animal. Such points of distinction include, but are not limited to, significantly reduced or substantially no: steroid hormones, antibiotics, or microbial contamination; lower fat content; no vasculature; and extended shelf life both at room temperature and when refrigerated.

The present disclosure provides methods and compositions useful for the production of slaughter-free meat products, and the characterizations of the same. The slaughter-free meat products contain several points of distinction when compared to conventional meat procured by harvesting the tissue of a dead animal. Such points of distinction include, but are not limited to, significantly reduced or substantially no: steroid hormones, antibiotics, or microbial contamination; lower fat content; no vasculature; and extended shelf life both at room temperature and when refrigerated.

A composition comprising at least about 25% of a fiber component, by weight of the composition, provides a safe and effective amount of fiber component to a user. A method of producing such a composition is provided. Additionally a method of providing a safe and effective amount of fiber component to a user is provided.